Business Context and Reporting Period
Company: Eastman Chemical Company
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2000
Reporting Segments: Effective Q1 2000, operations are reported in two segments: Chemicals and Polymers (reclassified from three segments in 1999).
Key Financial Metrics
| Metric ($ millions) | Q3 2000 | Q3 1999 | 9 Months 2000 | 9 Months 1999 |
|---|---|---|---|---|
| Sales | $1,387 | $1,190 | $3,920 | $3,335 |
| Gross Profit | $291 | $214 | $831 | $634 |
| Gross Margin | 21.0% | 18.0% | 21.2% | 19.0% |
| Operating Earnings | $154 | $75 | $459 | $242 |
| Net Earnings | $97 | $33 | $251 | $100 |
| Diluted EPS | $1.27 | $0.42 | $3.26 | $1.27 |
| Operating Cash Flow (9mo) | $563 (2000) vs $495 (1999) | |||
| Total Debt | $2,140 (Sep 30, 2000) vs $2,105 (Dec 31, 1999) | |||
| Cash & Equivalents | $74 (Sep 30, 2000) vs $186 (Dec 31, 1999) |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 17% in Q3 and 18% for the first nine months of 2000. Growth was driven by significantly higher selling prices (offsetting raw material cost increases) and volume from acquisitions (McWhorter Technologies and Sokolov).
- Profitability: Operating earnings surged 105% in Q3 and 90% year-to-date. Gross margins improved due to price increases, lower cost structures, and higher capacity utilization.
- Non-Recurring Items:
- Gain: A $38 million pre-tax gain was recorded in Q3 2000 from the initial public offering of Genencor International, Inc.
- Charges: A $9 million write-off of acquired in-process R&D (McWhorter) and a $4 million charge for exiting the sorbates product line impacted earnings.
- Foreign Currency: The decline in the value of the euro negatively impacted revenue and earnings.
- Interest Expense: Increased 9% in Q3 and 18% year-to-date due to higher commercial paper borrowings for acquisitions and reduced capitalized interest.
Guidance, Outlook, and Risks
- Outlook: Management expects Q4 2000 earnings per share to be at the lower end of analysts' estimates ($0.70 to $0.89). Volume growth is expected to slow in 2001 but exceed GDP growth.
- Cost Pressures: Raw material costs are expected to increase in Q4 2000. Hedging activities may result in diminished savings. Price increases effective October 1, 2000, are expected to offset some costs.
- Strategic Initiatives:
- Plans to divest a major portion of the fine chemicals business.
- Letter of intent to acquire hydrocarbon and rosin resins businesses from Hercules Incorporated (expected completion Q4 2000).
- Target to eliminate $100 million in non-labor costs by year-end 2000.
- Risks:
- Legal: Ongoing antitrust litigation regarding sorbates (price-fixing) in the US and Canada; tentative settlements reached in some cases but outcomes remain uncertain.
- Environmental: Compliance with complex regulations; potential for unanticipated enforcement actions.
- Market: Exposure to foreign currency fluctuations and raw material price volatility.
Investor Verification Checklist
- Acquisition Integration: Verify the financial contribution and integration status of McWhorter Technologies and Sokolov.
- Genencor Gain: Confirm the sustainability of earnings excluding the one-time $38 million Genencor IPO gain.
- Debt Structure: Review the classification of $511 million in commercial paper as long-term debt due to the new 2005 credit facility maturity.
- Legal Exposure: Monitor the status of sorbates antitrust litigation settlements and potential liability.
- Raw Material Hedging: Assess the effectiveness of hedging strategies against rising energy and feedstock costs in Q4 2000.